Literature DB >> 11166273

Collateral and collateral-adjacent hyperemic vascular resistance changes and the ipsilateral coronary flow reserve. Documentation of a mechanism causing coronary steal in patients with coronary artery disease.

M Billinger1, M Fleisch, F R Eberli, B Meier, C Seiler.   

Abstract

OBJECTIVES: The goal of this clinical study was to assess the influence of hyperemic ipsilateral, collateral and contralateral vascular resistance changes on the coronary flow velocity reserve (CFVR) of the collateral-receiving (i.e. ipsilateral) artery, and to test the validity of a model describing the development of collateral steal.
METHODS: In 20 patients with one- to two-vessel coronary artery disease (CAD) undergoing angioplasty of one stenotic lesion, adenosine induced intracoronary (i.c.) CFVR during vessel patency was measured using a Doppler guidewire. During stenosis occlusion, simultaneous i.c. distal ipsilateral flow velocity and pressure (P(occl), using a pressure guidewire) as well as contralateral flow velocity measurements via a third i.c. wire were performed before and during intravenous adenosine. From those measurements and simultaneous mean aortic pressure (P(ao)), a collateral flow index (CFI), and the ipsilateral, collateral, and contralateral vascular resistance index (R(ipsi), R(coll), R(contra)) were calculated. The study population was subdivided into groups with CFI<0.15 and with CFI> or =0.15.
RESULTS: The percentage-diameter coronary artery stenosis (%-S) to be dilated was similar in the two groups: 78+/-10% versus 82+/-12% (NS). CFVR was not associated with %-S. In the group with CFI> or =0.15 but not with CFI<0.15, CFVR was directly and inversely associated with R(coll) and R(contra), respectively.
CONCLUSIONS: A hemodynamic interaction between adjacent vascular territories can be documented in patients with CAD and well developed collaterals among those regions. The CFVR of a collateralized region may, thus, be more dependent on hyperemic vascular resistance changes of the collateral and collateral-supplying area than on the ipsilateral stenosis severity, and may even fall below 1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11166273     DOI: 10.1016/s0008-6363(00)00175-9

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  7 in total

1.  Estimation of coronary flow reserve: can SPECT compete with other modalities?

Authors:  G T Gullberg; E V Di Bella; A J Sinusas
Journal:  J Nucl Cardiol       Date:  2001 Sep-Oct       Impact factor: 5.952

2.  Effects of exercise training on cellular mechanisms of endothelial nitric oxide synthase regulation in coronary arteries after chronic occlusion.

Authors:  Minglong Zhou; R Jay Widmer; Wei Xie; A Jimmy Widmer; Matthew W Miller; Friedhelm Schroeder; Janet L Parker; Cristine L Heaps
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-02       Impact factor: 4.733

Review 3.  The dynamics of the coronary collateral circulation.

Authors:  Marco Zimarino; Mariangela D'Andreamatteo; Ron Waksman; Stephen E Epstein; Raffaele De Caterina
Journal:  Nat Rev Cardiol       Date:  2014-01-07       Impact factor: 32.419

4.  Postischemic stunning after adenosine vasodilator stress.

Authors:  Regina S Druz; Olakunle A Akinboboye; Roger Grimson; Kenneth J Nichols; Nathaniel Reichek
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

Review 5.  Pathophysiology of coronary collaterals.

Authors:  Michael Stoller; Christian Seiler
Journal:  Curr Cardiol Rev       Date:  2014-02

Review 6.  Determinants of human coronary collaterals.

Authors:  Stefano F de Marchi
Journal:  Curr Cardiol Rev       Date:  2014-02

7.  Adenosine-Induced Coronary Steal Is Observed in Patients Presenting With ST-Segment-Elevation Myocardial Infarction.

Authors:  Muhammad Aetesam-Ur-Rahman; Adam J Brown; Catherine Jaworski; Joel P Giblett; Tian X Zhao; Denise M Braganza; Sarah C Clarke; Bobby S K Agrawal; Martin R Bennett; Nick E J West; Stephen P Hoole
Journal:  J Am Heart Assoc       Date:  2021-06-30       Impact factor: 6.106

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.